Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the ...

For the past five years, it seems that we have been addressing constant change in our operating environment driven by ...

Zenity, a leading end-to-end security and governance platform for AI agents, today announced an inline prevention solution for Microsoft Foundry, created to meet enterprise security and compliance ...

AppsFlyer today announced the launch of eight new products designed to help businesses transform complex data into clarity and growth. The announcement underscores AppsFlyer's evolution from mobile ...

AI influencers are on the rise. But whether brands will pay their creators for advertisements is another story.